日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combination of PD-1/PD-L1 checkpoint inhibition and dendritic cell therapy in mice models and in patients with mesothelioma

在小鼠模型和间皮瘤患者中,PD-1/PD-L1 检查点抑制剂联合树突状细胞疗法

van Gulijk, Mandy; Belderbos, Bob; Dumoulin, Daphne; Cornelissen, Robin; Bezemer, Koen; Klaase, Larissa; Dammeijer, Floris; Aerts, Joachim

Immune monitoring in mesothelioma patients identifies novel immune-modulatory functions of gemcitabine associating with clinical response.

对间皮瘤患者的免疫监测发现了吉西他滨与临床反应相关的新型免疫调节功能

Dammeijer Floris, De Gooijer Cornedine J, van Gulijk Mandy, Lukkes Melanie, Klaase Larissa, Lievense Lysanne A, Waasdorp Cynthia, Jebbink Merel, Bootsma Gerben P, Stigt Jos A, Biesma Bonne, Kaijen-Lambers Margaretha E H, Mankor Joanne, Vroman Heleen, Cornelissen Robin, Baas Paul, Van der Noort Vincent, Burgers Jacobus A, Aerts Joachim G

Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model

树突状细胞疫苗接种和CD40激动剂联合疗法可在胰腺癌小鼠模型中诱导T细胞依赖性抗肿瘤免疫。

Lau, Sai Ping; van Montfoort, Nadine; Kinderman, Priscilla; Lukkes, Melanie; Klaase, Larissa; van Nimwegen, Menno; van Gulijk, Mandy; Dumas, Jasper; Mustafa, Dana A M; Lievense, Sanne L A; Groeneveldt, Christianne; Stadhouders, Ralph; Li, Yunlei; Stubbs, Andrew; Marijt, Koen A; Vroman, Heleen; van der Burg, Sjoerd H; Aerts, Joachim; van Hall, Thorbald; Dammeijer, Floris; van Eijck, Casper H J